The upcoming annual results presentation on March 11 represents a critical test for Porsche AG’s newly installed leadership team. As the company prepares to disclose its 2025 figures, a wave of downward revisions from market analysts underscores the challenging environment, with declining sales and earnings metrics casting a shadow over the event. The central question is whether management can credibly outline a path to recovery during this debut performance.
Operational Headwinds and Strategic Costs
Porsche’s operational landscape has grown increasingly difficult. Global vehicle deliveries for 2025 fell to 279,449 units, a decline of approximately 10% from the prior year’s 310,718. A significant portion of this weakness stems from the crucial Chinese market, where cooling luxury demand and intensified competition from domestic premium brands have led to a pronounced slump.
The financial strain is expected to be evident in the recent quarter’s results. Analysts anticipate earnings per share to drop to 0.38 euros, a sharp fall from 0.91 euros in the comparable period last year. Revenue is also projected to decline, with estimates pointing to 9.97 billion euros versus 11.52 billion euros previously.
Compounding these issues is a substantial 1.8 billion euro operational charge linked to the company’s revised electric vehicle strategy. Porsche continues to manage a costly dual-track approach: maintaining combustion engine production while the ramp-up of its electromobility segment progresses more slowly than initially planned. In response, the firm is emphasizing a “value over volume” strategy, granting renewed importance to hybrid and internal combustion models for their currently more stable margins. The all-electric Macan GTS is intended to bolster the EV offensive, but these product ambitions confront a weaker Chinese market and declining European registrations.
Should investors sell immediately? Or is it worth buying Porsche AG?
Analyst Sentiment Turns Cautious
This gathering pressure is reflected in recent adjustments from financial research firms. Goldman Sachs reduced its price target on Porsche shares from 46 to 40 euros, maintaining a “Neutral” stance. The firm cited a challenging outlook for 2026 and 2027, noting that a potential new model offensive may not provide tangible relief until 2028. Similarly, UBS revised its target downward to 42 euros.
A slightly more optimistic note comes from Kepler Cheuvreux, which highlighted the potential for positive cash conversion in the 2026 financial year and suggested Porsche may have already passed the low point in its earnings cycle. Nevertheless, the consensus view identifies a common problem: a lack of clear, near-term catalysts to drive the share price higher.
Technical and Market Performance Reflects Pressure
The stock’s market performance mirrors these fundamental concerns. Trading near 39.49 euros, the shares are hovering just above their 52-week low of 39.21 euros and have depreciated by 16.71% since the start of the year. From a chart perspective, the situation remains tense, with the current price sitting roughly 7% below the 50-day moving average of 42.50 euros and nearly 10% below the 200-day moving average of 43.76 euros.
Leadership’s Crucial Debut
For CEO Dr. Michael Leiters, who assumed his role on January 1, 2026, and CFO Dr. Jochen Breckner, the March 11 report is more than a routine obligation. It marks the first occasion Porsche will provide a comprehensive outlook under its new executive duo. Investors will be listening closely for two key elements: a 2026 forecast that convincingly supports a narrative of stabilization, and a strategic roadmap from Leiters and Breckner that appears robust enough to withstand ongoing sales pressure and EV-related costs.
Ad
Porsche AG Stock: Buy or Sell?! New Porsche AG Analysis from March 5 delivers the answer:
The latest Porsche AG figures speak for themselves: Urgent action needed for Porsche AG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 5.
Porsche AG: Buy or sell? Read more here...
